Pharma

Your Article Summary

See Latest Articles

Tigecycline (Tygacil): Tetracycline-class antibiotic approved for the treatment of community-acquired bacterial pneumonia
Formulary , 05/19/09

Tigecycline is a glycylcycline antibiotic that exerts its antibacterial effects by inhibiting protein translation in bacteria. Tigecycline was approved on March 2009, for the treatment of community-acquired bacterial pneumonia caused by Streptococcus pneumoniae, including cases with concurrent bacteremia, Haemophilus influenzae, and Legionella pneumophila.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals